Global Healthcare Claims Management Market Expected to Grow at 5% CAGR

The healthcare claims management market is expected to grow at a compound annual growth rate (CAGR) of approximately 5% over the forecast period from 2023 to 2030. According to a report by Medi-Tech Insights, the market is driven by rising healthcare expenditures, the rapid growth of the health insurance sector, and increasing adoption of revenue cycle management (RCM) solutions. The report also highlights the shift toward digital and cloud-based platforms, the expanding use of artificial intelligence (AI) and advanced analytics in claims processing, the transition to value-based care models, and the accelerating adoption of telemedicine and remote healthcare services.

Healthcare claims management encompasses the end-to-end process of handling medical insurance claims, from initial submission through final reimbursement. This process includes patient eligibility verification, medical coding, regulatory compliance checks, payment processing, and denial management. Effective claims management aims to streamline workflows, reduce errors, prevent fraud, and ensure timely reimbursements for healthcare providers while maintaining compliance with payer policies and government regulations.

The increasing adoption of AI and analytics is a key driver of market growth. Automation and AI technologies are transforming healthcare insurance claims management by reducing manual workloads, improving operational efficiency, and enhancing accuracy. AI-powered chatbots and virtual assistants provide real-time customer support, while automated claims processing systems handle repetitive tasks such as data entry and document validation. In addition, AI-driven fraud detection algorithms enable insurers to proactively identify suspicious claims and mitigate financial risk. Advanced analytics and predictive modeling further enhance claims management by analyzing historical data to identify trends, detect anomalies, optimize resource allocation, flag high-risk claims, and accelerate claim settlements, ultimately improving customer satisfaction and reducing operational costs.

The competitive landscape of the global healthcare claims management market features a mix of established and emerging players, including McKesson Corporation, The SSI Group, Inc., Quest Diagnostics, Kareo, Optum, Inc. (a subsidiary of UnitedHealth Group), Conifer Health Solutions, CareCloud, eClinicalWorks, IBM, Cerner Corporation, Oracle Corporation, Cognizant, and Change Healthcare, among others. Key competitive strategies employed by market participants include product innovation, strategic partnerships and collaborations, and ongoing investments in technology and infrastructure.

The report provides a detailed market segmentation by product, component, solution type, deployment mode, and end user. By product, the market is segmented into medical billing, professional billing, institutional billing, and claims processing. By component, it is divided into software and services. By solution type, the market is categorized into integrated solutions and standalone solutions. By deployment mode, it is segmented into on-premise, web-based, and cloud-based. By end user, the market is segmented into healthcare providers, healthcare payers, and others.

The regional analysis covers North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to contribute significantly to the market growth, followed by Europe and Asia Pacific. The report also provides a regional forecast by country-level from 2023 to 2030.

Medi-Tech Insights, a healthcare-focused business research and insights firm, has completed over 100 projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices, and Pharma Services. The firm's clients include Fortune 500 companies, blue-chip investors, and hyper-growth start-ups.

The report on the antibody testing market, which is expected to expand at a CAGR of approximately 6% between 2025 and 2030, is also part of the same release. This growth is primarily driven by the increasing burden of infectious and chronic diseases, rising demand for diagnostic and monitoring solutions, and continued innovation in antibody-based technologies, including multiplex assays and automated testing systems.

The custom antibody market is projected to grow at a CAGR of approximately 10% throughout the forecast period. This expansion is driven by increasing R&D activity, rising demand for highly specific antibodies, greater adoption of targeted therapeutics, and continuous advancements in antibody engineering and production technologies.

The report on the digital therapeutics market, which is expected to reach USD 30.65 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2025 to 2032, is also part of the same release. This market is segmented on the basis of application, distribution channel, and geography. The application segment includes respiratory diseases, central nervous system diseases, smoking cessation, medication adherence, cardiovascular diseases, musculoskeletal diseases, and other applications. Based on distribution channel, the market is segmented as B2B and B2C.

The report on the digital therapeutics market, which is expected to reach USD 30.65 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2025 to 2032, is also part of the same release. This market is segmented on the basis of application, distribution channel, and geography. The application segment includes respiratory diseases, central nervous system diseases, smoking cessation, medication adherence, cardiovascular diseases, musculoskeletal diseases, and other applications. Based on distribution channel, the market is segmented as B2B and B2C.

The report on the digital therapeutics market, which is expected to reach USD 30.65 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2025 to 2032, is also part of the same release. This market is segmented on the basis of application, distribution channel, and geography.